NO971376L - N-substituerte piperidinyl bisykliske benzoatderivater - Google Patents
N-substituerte piperidinyl bisykliske benzoatderivaterInfo
- Publication number
- NO971376L NO971376L NO971376A NO971376A NO971376L NO 971376 L NO971376 L NO 971376L NO 971376 A NO971376 A NO 971376A NO 971376 A NO971376 A NO 971376A NO 971376 L NO971376 L NO 971376L
- Authority
- NO
- Norway
- Prior art keywords
- 6alkyl
- substituted
- halo
- hydrogen
- alk
- Prior art date
Links
- 150000001558 benzoic acid derivatives Chemical class 0.000 title abstract 2
- -1 N-substituted piperidinyl Chemical group 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 12
- 125000001475 halogen functional group Chemical group 0.000 abstract 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 3
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical group C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical group C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 abstract 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Chemical group C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 abstract 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical group COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 2
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 abstract 1
- 125000004845 (C1-C6) alkylsulfonylamino group Chemical group 0.000 abstract 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical group C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 abstract 1
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical class O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 125000000815 N-oxide group Chemical group 0.000 abstract 1
- 150000008641 benzimidazolones Chemical class 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 150000002012 dioxanes Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000004899 motility Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003216 pyrazines Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94202792 | 1994-09-27 | ||
| US45548695A | 1995-05-31 | 1995-05-31 | |
| PCT/EP1995/003691 WO1996010027A1 (en) | 1994-09-27 | 1995-09-19 | N-substituted piperidinyl bicyclic benzoate derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO971376D0 NO971376D0 (no) | 1997-03-24 |
| NO971376L true NO971376L (no) | 1997-05-05 |
| NO313238B1 NO313238B1 (no) | 2002-09-02 |
Family
ID=26136613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19971376A NO313238B1 (no) | 1994-09-27 | 1997-03-24 | N-substituerte piperidinyl bisykliske benzoatderivater |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0784620B1 (no) |
| JP (1) | JP3953097B2 (no) |
| CN (1) | CN1068880C (no) |
| AT (1) | ATE187453T1 (no) |
| AU (1) | AU699152B2 (no) |
| BR (1) | BR9509036A (no) |
| CA (1) | CA2200578C (no) |
| CZ (1) | CZ289031B6 (no) |
| DE (1) | DE69513846T2 (no) |
| DK (1) | DK0784620T3 (no) |
| ES (1) | ES2141383T3 (no) |
| FI (1) | FI119640B (no) |
| GR (1) | GR3032646T3 (no) |
| HU (1) | HU218698B (no) |
| IL (1) | IL115413A (no) |
| MY (1) | MY113202A (no) |
| NO (1) | NO313238B1 (no) |
| NZ (1) | NZ293605A (no) |
| PL (1) | PL182502B1 (no) |
| PT (1) | PT784620E (no) |
| RU (1) | RU2154064C2 (no) |
| WO (1) | WO1996010027A1 (no) |
| ZA (1) | ZA958081B (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2332275A1 (en) * | 1998-05-14 | 1999-11-18 | Zoltan Tamas Nagy | Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient |
| DE60300683T2 (de) * | 2002-01-16 | 2006-04-27 | Janssen Pharmaceutica N.V. | Prucaloprid-n-oxid |
| JP4740152B2 (ja) | 2003-12-23 | 2011-08-03 | セロドス アクスイェ セルスカブ | 末梢性5−ht受容体の修飾因子 |
| US8071624B2 (en) | 2004-06-24 | 2011-12-06 | Incyte Corporation | N-substituted piperidines and their use as pharmaceuticals |
| CN102775396B (zh) | 2005-11-08 | 2014-10-08 | 沃泰克斯药物股份有限公司 | Atp-结合弹夹转运蛋白的杂环调控剂 |
| CN104447716A (zh) | 2007-05-09 | 2015-03-25 | 沃泰克斯药物股份有限公司 | Cftr调节剂 |
| MX365732B (es) | 2007-12-07 | 2019-06-12 | Vertex Pharma | Procesos para producir acidos cicloalquilcarboxamido-piridin benzoicos. |
| EP3683218B1 (en) | 2007-12-07 | 2024-09-18 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
| NZ720282A (en) | 2008-02-28 | 2017-12-22 | Vertex Pharma | Heteroaryl derivatives as cftr modulators |
| MX2012011655A (es) * | 2010-04-07 | 2012-11-23 | Vertex Pharma | Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo [d][1-3]dioxol-5-il]ciclopropanocarboxamido)-3-metilpiridin-2-il) benzoico. |
| JP2013523833A (ja) | 2010-04-07 | 2013-06-17 | バーテックス ファーマシューティカルズ インコーポレイテッド | 3−(6−(1−(2,2−ジフルオロベンゾ[d][1,3]ジオキソール−5−イル)シクロプロパンカルボキサミド)−3−メチルピリジン−2−イル)安息香酸の医薬組成物およびその投与 |
| NZ727015A (en) | 2012-01-25 | 2017-12-22 | Vertex Pharma | Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| AU2014349010C1 (en) | 2013-11-12 | 2020-08-06 | Vertex Pharmaceuticals Incorporated | Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases |
| RU2691136C2 (ru) | 2014-11-18 | 2019-06-11 | Вертекс Фармасьютикалз Инкорпорейтед | Способ проведения высокопроизводительной тестовой высокоэффективной жидкостной хроматографии |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1593569A3 (ru) * | 1982-07-30 | 1990-09-15 | Janssen Pharmaceutica Nv | Cпocoб пoлучehия пpoизboдhыx n-(3-гидpokcи-4-пипepидиhил)бehзamидa или иx kиcлotho-aддиtиbhыx coлeй |
| CA1317940C (en) * | 1987-09-25 | 1993-05-18 | Georges H. P. Van Daele | Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
| DE3810552A1 (de) * | 1988-03-29 | 1989-10-19 | Sandoz Ag | Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben |
| US5374637A (en) * | 1989-03-22 | 1994-12-20 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
| GB9005014D0 (en) * | 1990-03-06 | 1990-05-02 | Janssen Pharmaceutica Nv | N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives |
| CA2116024A1 (en) * | 1991-08-20 | 1993-03-04 | Francis David King | 5-ht4 receptor antagonists |
| MX9306311A (es) * | 1992-10-13 | 1994-04-29 | Smithkline Beecham Plc | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen |
-
1995
- 1995-09-19 WO PCT/EP1995/003691 patent/WO1996010027A1/en not_active Ceased
- 1995-09-19 JP JP51133896A patent/JP3953097B2/ja not_active Expired - Fee Related
- 1995-09-19 AU AU36081/95A patent/AU699152B2/en not_active Ceased
- 1995-09-19 AT AT95933400T patent/ATE187453T1/de not_active IP Right Cessation
- 1995-09-19 RU RU97107464/04A patent/RU2154064C2/ru not_active IP Right Cessation
- 1995-09-19 BR BR9509036A patent/BR9509036A/pt not_active IP Right Cessation
- 1995-09-19 DK DK95933400T patent/DK0784620T3/da active
- 1995-09-19 NZ NZ293605A patent/NZ293605A/en not_active IP Right Cessation
- 1995-09-19 HU HU9701944A patent/HU218698B/hu not_active IP Right Cessation
- 1995-09-19 ES ES95933400T patent/ES2141383T3/es not_active Expired - Lifetime
- 1995-09-19 EP EP95933400A patent/EP0784620B1/en not_active Expired - Lifetime
- 1995-09-19 PL PL95319997A patent/PL182502B1/pl not_active IP Right Cessation
- 1995-09-19 CZ CZ1997918A patent/CZ289031B6/cs not_active IP Right Cessation
- 1995-09-19 DE DE69513846T patent/DE69513846T2/de not_active Expired - Lifetime
- 1995-09-19 CN CN95195300A patent/CN1068880C/zh not_active Expired - Fee Related
- 1995-09-19 CA CA002200578A patent/CA2200578C/en not_active Expired - Lifetime
- 1995-09-19 PT PT95933400T patent/PT784620E/pt unknown
- 1995-09-22 IL IL11541395A patent/IL115413A/xx not_active IP Right Cessation
- 1995-09-26 ZA ZA958081A patent/ZA958081B/xx unknown
- 1995-09-26 MY MYPI95002870A patent/MY113202A/en unknown
-
1997
- 1997-03-24 NO NO19971376A patent/NO313238B1/no not_active IP Right Cessation
- 1997-03-26 FI FI971274A patent/FI119640B/fi active
-
2000
- 2000-02-11 GR GR20000400344T patent/GR3032646T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971376D0 (no) | N-substituerte piperidinyl bisykliske benzoatderivater | |
| ES449191A1 (es) | Un procedimiento de preparacion de derivados de 4,5,6,7-te- trahidro-tieno-(2,3-c)-piridina. | |
| TW369526B (en) | Diazabicyclic neurokinin antagonists | |
| DE60040901D1 (de) | Polyhydroxyalkanoat | |
| DK0447285T3 (da) | Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem | |
| MY101359A (en) | 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation | |
| DE60139639D1 (de) | Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung | |
| DK0479546T3 (da) | Piperazinderivater | |
| ATE282610T1 (de) | Heterozyklische verbindungen mit faktor xa hemmender wirkung | |
| MY120248A (en) | Water soluble azoles as broad-spectrum antifungals | |
| ATE171943T1 (de) | Piperidin-verbindungen, ihre darstellung und ihre verwendung | |
| PL322872A1 (en) | Novel triazolones - inhibitors of b apolipoprotein synthesis | |
| TW360653B (en) | A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition | |
| ATE212996T1 (de) | Anthracyclin-derivate | |
| DK1150974T3 (da) | Heterocykliske derivater som inhibitor af faktor Xa | |
| AP1396A (en) | 1-Trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives. | |
| HUP9900895A2 (hu) | Simaizom sejtburjánzást gátló 2-szubsztituált benzimidazolszármazékok | |
| JO1648B1 (en) | Nitrogen compounds | |
| JO1697B1 (en) | Pyridine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |